Regeneron Pharma (REGN) PT Lowered to $152 at Jefferies
Tweet Send to a Friend
Jefferies analyst Akash Tewari lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $152.00 (from $160.00) while maintaining a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
